US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, June 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 6,102 followers.

RT @Abdallah81MD: Selinexor 8 tablets cost $24,000 how does this statement makes any sense with a poor response!!! #mmsm #MedTwitter #MedEd…

Selinexor 8 tablets cost $24,000 how does this statement makes any sense with a poor response!!! #mmsm #MedTwitter #MedEd #USMIRC @USMIRCNEWS https://t.co/O2bcdeEX5R https://t.co/hzMnQwbhOe

@ManniMD1 @IMFmyeloma Thanks. Yes we factored in the cost of managing AE as published by Bassali et al. https://t.co/Y9JVE8LZ5Y

@justine_ryu Agree. Some other examples in heme: Defibrotide https://t.co/e04tPMcJNX Selinexor https://t.co/3r0k5pw4Fk

New article: US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma. https://t.co/9WfQPm3J6c #MMSM #MultipleMyeloma #hematology https://t.co/0mZTwdxkK3